Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Anemia, Sickle Cell D000755 34 associated lipids
Aspergillosis D001228 5 associated lipids
Blastomycosis D001759 5 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dermatomycoses D003881 17 associated lipids
Gonorrhea D006069 7 associated lipids
Hemolysis D006461 131 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hypertension D006973 115 associated lipids
Influenza, Human D007251 11 associated lipids
Leishmaniasis D007896 19 associated lipids
Mycoses D009181 18 associated lipids
Otitis Externa D010032 8 associated lipids
Peritonitis D010538 38 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Urethritis D014526 9 associated lipids
Vaginitis D014627 6 associated lipids
Xerostomia D014987 6 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Kristanc L et al. Effects of the pore-forming agent nystatin on giant phospholipid vesicles. 2012 Biochim. Biophys. Acta pmid:22178865
Kaufman DA "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. 2012 Early Hum. Dev. pmid:22633513
Khan MA et al. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice. 2012 FEMS Immunol. Med. Microbiol. pmid:22612788
Shanmughapriya S et al. In vitro actinomycete biofilm development and inhibition by the polyene antibiotic, nystatin, on IUD copper surfaces. 2012 Biofouling pmid:22963125
Kaomongkolgit R et al. Antifungal activity of coronarin D against Candida albicans. 2012 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22727093
Fernández Campos F et al. Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. 2012 J Pharm Sci pmid:22777575
Baugé C et al. Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes. 2012 Biochim. Biophys. Acta pmid:22425785
Leibovitz E Strategies for the prevention of neonatal candidiasis. 2012 Pediatr Neonatol pmid:22503254
Bhattacharya S et al. DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. 2012 Nano Lett. pmid:22375622
Al-Dwairi ZN et al. The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. 2012 J Prosthodont Res pmid:22841909
Giglio M et al. Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial. 2012 Crit Care pmid:22490643
Xu L et al. Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. 2011 May-Jun Mol Med Rep pmid:21468584
Brito GN et al. In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. 2011 Jan-Feb Braz Oral Res pmid:21271179
Mane RS et al. Synthesis of an adenine nucleoside containing the (8'R) epimeric carbohydrate core of amipurimycin and its biological study. 2011 J. Org. Chem. pmid:21381774
Jeon HG et al. Analysis and functional expression of NPP pathway-specific regulatory genes in Pseudonocardia autotrophica. 2011 J. Ind. Microbiol. Biotechnol. pmid:21259033
Acar A et al. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. 2011 Burns pmid:21354707
Villa NY et al. Phylogenetic and preliminary phenotypic analysis of yeast PAQR receptors: potential antifungal targets. 2011 J. Mol. Evol. pmid:22009226
Frey Tirri B Antimicrobial topical agents used in the vagina. 2011 Curr. Probl. Dermatol. pmid:21325838
Brautaset T et al. New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei. 2011 Appl. Environ. Microbiol. pmid:21764946
Chao TY and Raines RT Mechanism of ribonuclease A endocytosis: analogies to cell-penetrating peptides. 2011 Biochemistry pmid:21827164